Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.
P/E ratio for Nexstim Plc (NXTMH.HE)
P/E ratio as of 2023: -14.70
According to Nexstim Plc's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -14.70. At the end of 2022 the company had a P/E ratio of 21.06.
P/E ratio history for Nexstim Plc from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -14.70 |
| 2022 | 21.06 |
| 2021 | -34.86 |
| 2020 | -6.35 |
| 2019 | -0.49 |
| 2018 | -0.08 |
| 2017 | -3.11 |
| 2016 | -0.28 |
| 2015 | -4.70 |
| 2014 | -2.59 |
| 2013 | -6.48 |
| 2012 | -10.85 |